Health

Eli Lilly to Launch its Blockbuster Drug ‘Tirzepatide’ in India in 2025

U.S. pharmaceutical company Eli Lilly plans to introduce its blockbuster drug 'Tirzepatide' to India in 2025. The drug, renowned for treating type 2 diabetes...

India Launches Special 100-Day TB Elimination Campaign Focused on High Burden Districts

India Launches Special 100-Day TB Elimination Campaign Focused on High Burden Districts In a major push to eliminate tuberculosis (TB), Prime Minister Narendra Modi today...

Cities in India at Risk due of High NO₂ Levels

The Indian cities at risk due to high toxic Nitrogen dioxide (NO₂) levels in the atmosphere, according to a report ‘Beyond North India: NO₂...

Study Finds Women from high-income quintiles prefer C-sections

A new study found that more women from high-income quintiles are having caesarean sections (C-sections), even in govt hospitals where the procedure is free. Only...

Lilly’s Zepbound tops Novo’s Wegovy in a weight loss drug trial

Eli Lilly said on Wednesday, patients taking its weight loss drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy...

Popular

Subscribe

spot_imgspot_img